A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
PHASE2
An open label randomised trial for adults with histologically confirmed mea...
Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
PHASE2
The purpose of this study is to assess the efficacy of single-agent regoraf...
Status
Terminated
Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions
N/A
This is an observational study using data that has been collected from part...